Abbott India Ltd
ABBOTINDIABSE 500488PharmaceuticalsMkt cap ₹57,016 Cr
Parent company only — BSE has no complete consolidated figures for this company.
Revenue · Q1 FY27
₹1,814 Cr
YoY +4.3%QoQ +6.1%
Net profit · Q1 FY27
₹429 Cr
YoY +17.1%QoQ +8.5%
Net margin · Q1 FY27
23.6%
+2.6 pts vs Q1 FY26
Net profit · FY26
₹1,552 Cr
YoY +9.7%
Quarterly results
| ₹ Cr | Q1 FY27 Apr–Jun 2026 | Q4 FY26 Jan–Mar 2026 | Q3 FY26 Oct–Dec 2025 | Q2 FY26 Jul–Sep 2025 | Q1 FY26 Apr–Jun 2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | 1,814 | 1,710 | 1,724 | 1,757 | 1,738 | +4.3% |
| Other income | 75.37 | 75.59 | 69.76 | 69.95 | 72.84 | +3.5% |
| Total income | 1,889 | 1,785 | 1,794 | 1,827 | 1,811 | +4.3% |
| Expenses | 1,297 | 1,235 | 1,266 | 1,263 | 1,299 | -0.1% |
| Interest | 5.91 | 6.14 | 5.48 | 7.55 | 5.82 | +1.5% |
| Depreciation | 19.75 | 19.07 | 18.77 | 18.64 | 19.48 | +1.4% |
| Profit before tax | 572 | 531 | 509 | 546 | 493 | +16.0% |
| Tax | 144 | 136 | 133 | 131 | 127 | +12.9% |
| Net profit | 429 | 395 | 376 | 415 | 366 | +17.1% |
| Operating margin | 33.0% | 32.5% | 30.9% | 32.6% | 29.8% | |
| Net margin | 23.6% | 23.1% | 21.8% | 23.6% | 21.1% | |
| EPS (₹) | 201.66 | 185.85 | 176.92 | 195.42 | 172.17 |
Annual results
| ₹ Cr | FY26 Apr 2025–Mar 2026 | FY25 Apr 2024–Mar 2025 | FY24 Apr 2023–Mar 2024 | FY23 Apr 2022–Mar 2023 | FY22 Apr 2021–Mar 2022 | YoY |
|---|---|---|---|---|---|---|
| Revenue | 6,929 | 6,409 | 5,849 | 5,349 | 4,919 | +8.1% |
| Other income | 288 | 276 | 248 | 154 | 77.21 | +4.6% |
| Total income | 7,217 | 6,685 | 6,097 | 5,503 | 4,996 | +8.0% |
| Expenses | 5,062 | 4,726 | 4,408 | 4,159 | 3,851 | +7.1% |
| Interest | 24.99 | 11.43 | 12.45 | 15.99 | 19.10 | +118.6% |
| Depreciation | 75.96 | 71.80 | 71.17 | 69.97 | 66.10 | +5.8% |
| Profit before tax | 2,079 | 1,887 | 1,618 | 1,274 | 1,080 | +10.2% |
| Tax | 527 | 473 | 417 | 324 | 281 | +11.6% |
| Net profit | 1,552 | 1,414 | 1,201 | 949 | 799 | +9.7% |
| Operating margin | 31.5% | 30.7% | 29.1% | 25.4% | 23.7% | |
| Net margin | 22.4% | 22.1% | 20.5% | 17.8% | 16.2% | |
| EPS (₹) | 730.36 | 665.62 | 565.28 | 446.78 | 375.86 |
BIC's take
We haven't covered Abbott India Ltd yet. Browse our sector reports →
Source: BSE filings · Data as of 2 Oct 2026, 6:33 pm IST· ₹ crore unless stated. Covers BSE 500 companies only. Consolidated figures include subsidiaries; standalone is the parent company alone. Growth is shown only against a positive base. Not investment advice — check the company's full filing before acting.